Centuple Global Ltd

NSE: RUBRAME · BSE: 531099 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹32.91
Market cap: ₹18.00 Cr
Revenue (annual): ₹573.8 Cr
Net profit (annual): ₹1.51 Cr
P/E (TTM): 14.6×Sector 50.4×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 11.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 2 Financial Results 2 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Sep 2026 12:42 IST BSE

Board Meeting Outcome

Centuple Global Board Meeting Outcome

Centuple Global appointed Ms. Neha Varshney as an Independent Director. The board also approved related party transactions and a director loan for the upcoming fiscal.

Read the filing ↗